| Indicator |
Points |
Target |
Practice |
| Records |
|
|
|
| CHD 1. The practice can produce a register of patients with
coronary heart disease |
4 |
|
|
| Diagnosis and initial management |
|
|
|
| CHD 2. The percentage of patients with newly diagnosed angina
(diagnosed after 1 April 2003) who are referred for exercise testing and/or
specialist assessment |
7 |
90% |
|
| Ongoing Management |
|
|
|
| CHD 5. The percentage of patients with coronary heart disease
whose notes have a record of blood pressure in the previous 15 months |
7 |
90% |
|
| CHD 6. The percentage of patients with coronary heart disease
in whom the last blood pressure reading (measured in the previous 15 months)
is 150/90 or less |
19 |
70% |
|
| CHD 7. The percentage of patients with coronary heart disease
whose notes have a record of total cholesterol in the previous 15 months |
7 |
90% |
|
| CHD 8. The percentage of patients with coronary heart disease
whose last measured total cholesterol (measured in the previous 15 months)
is 5 mmol/l or less |
17 |
70% |
|
| CHD 9. The percentage of patients with coronary heart disease
with a record in the previous 15 months that aspirin, an alternative anti-platelet
therapy, or an anti-coagulant is being taken (unless a contraindication
or side-effects are recorded) |
7 |
90% |
|
| CHD 10. The percentage of patients with coronary heart disease
who are currently treated with a beta blocker (unless a contraindication
or side-effects are recorded) |
7 |
60% |
|
| CHD 11. The percentage of patients with a history of myocardial
infarction (diagnosed after 1 April 2003) who are currently treated with
an ACE inhibitor or Angiotensin II antagonist |
7 |
80% |
|
| CHD 12. The percentage of patients with coronary heart disease
who have a record of influenza immunisation in the preceding 1 September
to 31 March |
7 |
90% |
|
| Indicator |
Points |
Target |
Practice |
| Records |
|
|
|
| STROKE 1. The practice can produce a register of patients
with Stroke or TIA |
2 |
|
|
| STROKE 13. The percentage of new patients with a stroke or TIA who
have been referred for further investigation. |
2 |
80% |
|
| Ongoing Management |
|
|
|
| STROKE 5. The percentage of patients with TIA or stroke who
have a record of blood pressure in the notes in the preceding 15 months |
2 |
90% |
|
| STROKE 6. The percentage of patients with a history of TIA
or stroke in whom the last blood pressure reading (measured in the previous
15 months) is 150/90 or less |
5 |
70% |
|
| STROKE 7. The percentage of patients with TIA or stroke who
have a record of total cholesterol in the last 15 months |
2 |
90% |
|
| STROKE 8. The percentage of patients with TIA or stroke whose
last measured total cholesterol (measured in the previous 15 months) is
5 mmol/l or less |
5 |
60% |
|
| STROKE 12. The percentage of patients with a stroke shown
to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet
agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant
is being taken (unless a contraindication or side-effects are recorded) |
4 |
90% |
|
| STROKE 10. The percentage of patients with TIA or stroke who
have had influenza immunisation in the preceding 1 September to 31 March |
2 |
85% |
|
| Indicator |
Points |
Target |
Practice |
| Records |
|
|
|
| DM 19.The practice can produce a register of all patients
aged 17 years and over with diabetes mellitus, which specifies whether the
patient has Type 1 or Type 2 diabetes. |
6 |
|
|
| Ongoing Management |
|
|
|
| DM 2.The percentage of patients with diabetes whose notes
record BMI in the previous 15 months |
3 |
90% |
|
| DM 5. The percentage of diabetic patients who have a record
of HbA1c or equivalent in the previous 15 months |
3 |
90% |
|
| DM 20. The percentage of patients with diabetes in whom the
last HbA1c is 7.5 or less (or equivalent test/reference range depending
on local laboratory) in the previous 15 months |
17 |
50% |
|
| DM 7. The percentage of patients with diabetes in whom the
last HbA1c is 10 or less (or equivalent test/reference range depending on
local laboratory) in the previous 15 months |
11 |
90% |
|
| DM 21. The percentage of patients with diabetes who have a
record of retinal screening in the previous 15 months |
5 |
90% |
|
| DM 9.The percentage of patients with diabetes with a record
of the presence or absence of peripheral pulses in the previous 15 months |
3 |
90% |
|
| DM 10. The percentage of patients with diabetes with a record
of neuropathy testing in the previous 15 months |
3 |
90% |
|
| DM 11. The percentage of patients with diabetes who have a
record of the blood pressure in the previous 15 months |
3 |
90% |
|
| DM 12. The percentage of patients with diabetes in whom the
last blood pressure is 145/85 or less |
18 |
60% |
|
| DM 13. The percentage of patients with diabetes who have a
record of micro-albuminuria testing in the previous 15 months (exception
reporting for patients with proteinuria) |
3 |
90% |
|
| DM 22. The percentage of patients with diabetes who have a
record of estimated glomerular filtration rate (eGFR) or serum creatinine
testing in the previous 15 months |
3 |
90% |
|
| DM 15. The percentage of patients with diabetes with a diagnosis
of proteinuria or micro-albuminuria who are treated with ACE inhibitors
(or A2 antagonists) |
3 |
80% |
|
| DM 16. The percentage of patients with diabetes who have a
record of total cholesterol in the previous 15 months |
3 |
90% |
|
| DM 17. The percentage of patients with diabetes whose last
measured total cholesterol within previous 15 months is 5 mmol/l or less |
6 |
70% |
|
| DM 18. The percentage of patients with diabetes who have had
influenza immunisation in the preceding 1 September to 31 March. |
3 |
85% |
|
| Indicator |
Points |
Target |
Practice |
| Records |
|
|
|
| MH 8. The practice can produce a register of people with schizophrenia,
bipolar disorder and other psychoses |
4 |
|
|
| Ongoing management |
|
|
|
| MH 9. The percentage of patients with schizophrenia, bipolar
affective disorder and other psychoses with a review recorded in the preceding
15 months. In the review there should be evidence that the patient has been
offered routine health promotion and prevention advice appropriate to their
age, gender and health status |
23 |
90% |
|
| MH 4. The percentage of patients on lithium therapy with a
record of serum creatinine and TSH in the preceding 15 months |
1 |
90% |
|
| MH 5. The percentage of patients on lithium therapy with a
record of lithium levels in the therapeutic range within the previous 6
months |
2 |
90% |
|
| MH6: The percentage of patients on the register who have a
comprehensive care plan documented in the records agreed between individuals,
their family and/or carers as appropriate |
6 |
50% |
|
| MH7: The percentage of patients with schizophrenia, bipolar
affective disorder and other psychoses who do not attend the practice for
their annual review who are identified and followed up by the practice team
within 14 days of non-attendance |
3 |
90% |
|
| Indicator |
Points |
Target |
Practice |
Ongoing management
|
|
|
|
| Smoking 3: The percentage of patients with any or any combination
of the following conditions: coronary heart disease, stroke or TIA, hypertension,
diabetes, COPD, CKD,asthma, schizophrenia, bipolar affective disorder or other psychoses whose notes record smoking status in the previous
15 months. Except those who have never smoked where smoking status need
only be recorded once since diagnosis |
33 |
90% |
|
| Smoking 4: The percentage of patients with any
or any combination of the following conditions: coronary heart disease,
stroke or TIA, hypertension, diabetes, COPD, CKD, asthma, schizophrenia, bipolar affective disorder or other psychoses who smoke whose notes
contain a record that smoking cessation advice or referral to a specialist
service, where available, has been offered within the previous 15 months |
35 |
90% |
|